富马酸沃诺拉赞 | 富马酸伏诺拉生| 1260141-27-2
Vonoprazan Fumarate | TAK-438
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Vonoprazan Fumarate | TAK-438
CAS881681-01-2
FormulaC17H16FN3O2S· C4H4O4
MW461.46 | 345.39 (Free)
AppearanceWhite to off-white powder
Storage condition4°C, sealed storage, away from moisture and light
Security information
Product details

Vonoprazan Fumarate, also known as TAK438, is a new medicine for treating acid-related diseases with a novel mechanism of action called potassium-competitive acid blockers (P-CABs) which competitively inhibits the binding of potassium ions to H+,K+-ATPase (also known as the proton pump) in the final step of gastric acid secretion in gastric parietal cells. TAKECAB provides a strong and sustained acid secretion inhibitory effect.

Related
Sorry, no related items
History
Sitaxsentan sodium | TBC11251 sodium salt | TBC11251
Vonoprazan Fumarate | TAK-438
Apatinib | Apatinib Free base | YN968D1| Rivoceranib
Camostat free base
Sapropterin | (6R)-BH4 | (6R)-Tetrahydro-L-biopterin)
Vorolanib (X-82,CM082)
Aliskiren Hemifumarate (Synonyms: CGP 60536 hemifumarate; CGP60536B hemifumarate; SPP 100 hemifumarate)
Alvimopan dihydrate (Synonyms: ADL 8-2698 dihydrate; LY 246736 dihydrate)
25-Hydroxycholesterol | Cholest-5-ene-3β,25-diol
Rivanicline | RJR-2403 | (E)-Metanicotine